Combined and sequential systemic chemotherapy and radiotherapy for treatment of brain metastases;Kombinierte und sequenzielle systemische chemotherapie und strahlentherapie bei hirnmetastasen

Onkologe

Volumn 14, Issue 3, 2008, Pages 255-259

  Korfel, A ^a   Hocht S ^a   Thiel, E ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Blood brain barrier; Brain metastases; Chemotherapy; Radiotherapy

Indexed keywords

BLEOMYCIN; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; FOTEMUSTINE; GEMCITABINE; IFOSFAMIDE; NAVELBINE; PACLITAXEL; TEMOZOLOMIDE; TENIPOSIDE; TOPOTECAN; VINBLASTINE; VINCRISTINE;

BRAIN METASTASIS; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DISEASE COURSE; HUMAN; LUNG CARCINOMA; LUNG NON SMALL CELL CANCER; MONOTHERAPY; REVIEW; TREATMENT RESPONSE;

EID: 40549132228     PISSN: 09478965     EISSN: 14330415     Source Type: Journal    
DOI: 10.1007/s00761-008-1318-0     Document Type: Review

References (29)

1. Andrews DW, Scott CB, Sperduto PW et al. (2004) Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: Phase III results of the RTOG 9508 randomised trial. Lancet 363: 1665-1672
2. Antonadou D, Paraskevaidis M, Sarris G et al. (2002) Phase II randomized trial of temozolomide and concurrent radiotherapy in patients with brain metastases. J Clin Oncol 20: 3644-3650
3. Aoyama H, Shirato H, Tago M et al. (2006) Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 295: 2483-2491
4. Bokemeyer C, Schmoll HJ, Harstrick A et al. (1993) A phase I/II study of a stepwise dose-escalated regimen of cisplatin, etoposide and ifosfamid plus granulocyte-macrophage colony stimulating factor (GM-CSF) in patients with advanced germ cell tumors. Eur J Cancer 29A: 2255-2231
5. Bokemeyer C, Nowak P, Haupt A et al. (1997) Treatment of brain metastases in patients with testicular cancer. J Clin Oncol 15: 1449-1454
6. Christodoulou C, Bafaloukos D, Kosmidis P et al. (2001) Phase II study of temozolomide in heavily pretreated cancer patients with brain metastases. Ann Oncol 12: 249-254
7. Dziadziuszko R, Ardizzoni A, Postmus PE et al. (2003) Temozolomide in patients with advanced non-small cell lung cancer with and without brain metastases: A phase II study of the EORTC Lung Cancer Group (08965). Eur J Cancer 39: 1271-1276
8. Eichler AF, Loeffler JS (2007) Multidisciplinary management of brain metastases. Oncologist 12: 884-898
9. Fossa SD, Bokemeyer C, Gerl A et al. (1998) Treatment outcome of patients with brain metastases from malignant germ cell tumors. Cancer 85: 988-997
10. Gaspar LE, Scott C, Murray K et al. (2000) Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases. Int J Radiat Oncol Biol Phys 47: 1001-1006
11. Kollmannsberger C, Nichols C, Bamberg M et al. (2000) First-line high-dose chemotherapy ± radiation therapy in patients with metastatic germ-cell cancer and brain metastases. Ann Oncol 11: 553-559
12. Kondziolka D, Martin JJ, Flickinger JC et al. (2005) Long-term survivors after gamma knife radiosurgery for brain metastases. Cancer 104: 2784-2791
13. Korfel A, Pawel J von, Oehm C et al. (2002) Response of symptomatic brain metastases of small-cell lung cancer to topotecan also after whole brain irradiation. Eur J Cancer 38: 1724-1729
14. Kristensen CA, Kristjansen PEG, Hansen HH (1992) Systemic chemotherapy of brain metastases from small-cell lung cancer: a review. J Clin Oncol 10: 1498-1157
15. Kristjansen PE, Soelberg Sørensen P, Skov Hansen M, Hansen HH (1993) Prospective evaluation of the effect on initial brain metastases from small cell lung cancer of platinum-etoposide based induction chemotherapy followed by an alternating multidrug regimen. Ann Oncol 7: 579-583
16. Lassman AB, Abrey LE, Shah GD et al. (2006) Systemic high-dose intravenous methotrexate for central nervous system metastases. J Neurooncol 78: 255-260
17. Lee JS (1986) Effects of brain irradiation and chemotherapy on myelosuppression in small-cell lung cancer. J Clin Oncol 4: 1615-1619
18. Mornex F, Thomas L, Mohr P et al. (2003) A prospective randomized multicentre phase III trial of fotemustine plus whole brain irradiation versus fotemustine alone in cerebral metastases of malignant melanoma. Melanoma Res 13: 97-103
19. Oberhoff C, Kieback DG, Wurstlein R et al. (2001) Topotecan chemotherapy in patients with breast cancer and brain metastases: Results of a pilot study. Onkologie 24: 256-260
20. Postmus PE, Haaxma-Reiche H, Smit EF et al. (2000) Treatment of brain metastases of small-cell lung cancer: comparing teniposide and teniposide with whole-brain radiotherapy - a phase III study of the European Organization for the Research and Treatment of Cancer Lung Cancer Cooperative Group. J Clin Oncol 18: 3400-3408
21. Postmus PE, Haaxma-Reiche H, Gregor A et al. (1996) The role of radiotherapy in the treatment of brain metastases of small-cell lung cancer. Proc Am Soc Clin Oncol 15: 381 (Abstract 1141)
22. Rivera E, Meyers C, Groves M et al. (2006) Phase I study of capecitabine in combination with temozolomide in the treatment of patients with brain metastases from breast carcinoma. Cancer 107: 1348-1354
23. Robinet G, Thomas P, Breton JL et al. (2001). Results of a phase III study of early versus delayed whole brain radiotherapy with concurrent cisplatin and vinorelbine combination in inoperable brain metastasis of non-small-cell lung cancer: Groupe Francais de Pneumo-Cancerologie (GFPC) Protocol 95-1. Ann Oncol 12: 59-67
24. Rosner D, Nemoto T, Lane WW (1986) Chemotherapy induces regression of brain metastases in breast carcinoma. Cancer 58: 832-839
25. Slotman B, Faivre-Finn C, Kramer G et al. (EORTC Radiation Oncology Group and Lung Cancer Group) (2007) Prophylactic cranial irradiation in extensive small-cell lung cancer. N Engl J Med 357: 664-672
26. Trudeau ME, Crump M, Charpentier D et al. (2006) Temozolomide in metastatic breast cancer (MBC): A phase II trial of the National Cancer Institute of Canada - Clinical Trials Group (NCIC-CTG). Ann Oncol 17: 952-956
27. Twelves CJ, Souhami RL, Harper PG et al. (1990) The response of cerebral metastases in small cell lung cancer to systemic chemotherapy. Br J Cancer 61: 147-150
28. Verger E, Gil M, Yaya R et al. (2005) Temozolomide and concomitant whole brain radiotherapy in patients with brain metastases: a phase II randomized trial. Int J Radiat Oncol Biol Phys 61: 185-191
29. Wong ET, Berkenblit A (2004) The role of topotecan in the treatment of brain metastases. Oncologist 9: 68-79